ScandiDos AB (SDOS) - Total Liabilities
Based on the latest financial reports, ScandiDos AB (SDOS) has total liabilities worth Skr24.31 Million SEK (≈ $2.62 Million USD) as of April 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See ScandiDos AB short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
ScandiDos AB - Total Liabilities Trend (2011–2026)
This chart illustrates how ScandiDos AB's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see ScandiDos AB (SDOS) total assets.
ScandiDos AB Competitors by Total Liabilities
The table below lists competitors of ScandiDos AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Era Mandiri Cemerlang Tbk PT
JK:IKAN
|
Indonesia | Rp54.14 Billion |
|
Vision Marine Technologies Inc
NASDAQ:VMAR
|
USA | $39.22 Million |
|
Creative Global Technology Holdings Limited Ordinary Shares
NASDAQ:CGTL
|
USA | $32.32K |
|
Accelerate Resources Ltd
AU:AX8
|
Australia | AU$569.73K |
|
BrenX Ltd.
NASDAQ:BRNX
|
USA | $9.00 Million |
|
Project Planning Service Public Company Limited
BK:PPS
|
Thailand | ฿302.93 Million |
|
Strategem Capital Corp
V:SGE
|
Canada | CA$54.00K |
Liability Composition Analysis (2011–2026)
This chart breaks down ScandiDos AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ScandiDos AB balance sheet quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ScandiDos AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ScandiDos AB (2011–2026)
The table below shows the annual total liabilities of ScandiDos AB from 2011 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-04-30 | Skr24.31 Million ≈ $2.62 Million |
-14.39% |
| 2025-04-30 | Skr28.40 Million ≈ $3.06 Million |
-23.63% |
| 2024-04-30 | Skr37.19 Million ≈ $4.00 Million |
+20.86% |
| 2023-04-30 | Skr30.77 Million ≈ $3.31 Million |
+6.14% |
| 2022-04-30 | Skr28.99 Million ≈ $3.12 Million |
-9.36% |
| 2021-04-30 | Skr31.98 Million ≈ $3.44 Million |
+29.27% |
| 2020-04-30 | Skr24.74 Million ≈ $2.66 Million |
-39.02% |
| 2019-04-30 | Skr40.57 Million ≈ $4.37 Million |
+107.55% |
| 2018-04-30 | Skr19.55 Million ≈ $2.10 Million |
+0.33% |
| 2017-04-30 | Skr19.48 Million ≈ $2.10 Million |
-23.57% |
| 2016-04-30 | Skr25.49 Million ≈ $2.74 Million |
+40.94% |
| 2015-04-30 | Skr18.09 Million ≈ $1.95 Million |
+35.93% |
| 2014-04-30 | Skr13.30 Million ≈ $1.43 Million |
-30.67% |
| 2013-04-30 | Skr19.19 Million ≈ $2.07 Million |
+58.75% |
| 2012-04-30 | Skr12.09 Million ≈ $1.30 Million |
+62.99% |
| 2011-04-30 | Skr7.42 Million ≈ $798.19K |
-- |
About ScandiDos AB
ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and software solutions for the quality assurance and validation of dynamic and modulated treatments adopted in clinics in the United States, Europe, Asia, and internationally. The company offers Delta4 products comprising Delta4 Phantom+, Delta4Phantom+MR, Delta4 HexaMotion, Delta4Insight, Delta4DVH Anatomy, Delta4… Read more